House Committee Chairs Clyburn, Maloney Reveal That Quality Failures by Emergent BioSolutions Rendered 135 Million Additional Coronavirus Vaccine Doses Unusable
August 12, 2022
August 12, 2022
WASHINGTON, Aug. 12 -- Rep. James E. Clyburn, D-South Carolina, chair of the House Select Subcommittee on the Coronavirus Crisis, issued the following news release:
Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released new evidence that 135 million coronavirus vaccine doses manufactured at Emergent BioSolutions' (Emergent) Bayview facility in Baltimore, Mar . . .
Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released new evidence that 135 million coronavirus vaccine doses manufactured at Emergent BioSolutions' (Emergent) Bayview facility in Baltimore, Mar . . .